All practice questions

8270 questions

Question 1321Question →

Match each patient's clinical presentation and diagnostic findings with the most appropriate targeted antimicrobial regimen.

Click a left item, then click its matching right item

Items

A 24-year-old pregnant patient at 10 weeks gestation evaluated in the outpatient clinic for an expanding annular rash with central clearing after an Appalachian trail hike.
A 65-year-old male admitted to the cardiovascular intensive care unit with a mechanical aortic valve, presenting with fever and blood cultures growing methicillin-resistant Staphylococcus aureus (MRSA).
A 35-year-old patient with untreated HIV and a CD4 count of 40 cells/mm³ evaluated in the infectious disease clinic for fever, weight loss, and blood cultures yielding Mycobacterium avium complex.
A 52-year-old female in the emergency department with acute pyelonephritis and septic shock; urine culture reveals Escherichia coli resistant to third-generation cephalosporins and aztreonam.

Matches

Show answer & explanation

Answer

The correct matches align the pregnant patient with Lyme disease to amoxicillin, the MRSA prosthetic valve endocarditis to vancomycin/gentamicin/rifampin, the disseminated MAC infection to a macrolide/ethambutol, and the ESBL pyelonephritis to a carbapenem.
Each correct pairing directly matches a complex infectious disease scenario with its definitive, guideline-directed antimicrobial regimen, carefully accounting for resistance mechanisms (ESBL), anatomical challenges (prosthetic biofilms), multidrug necessities (mycobacteria), and host safety factors (pregnancy).

Step-by-Step Solution

1
Identify the underlying pathogen and any host-specific contraindications for the pregnant patient.
Pathogen is Borrelia burgdorferi (Lyme disease). Doxycycline is contraindicated in pregnancy, making amoxicillin the correct choice.
Avoidance of teratogenic effects while ensuring effective clearance of the spirochete.
2
Determine the necessary regimen components for prosthetic valve endocarditis caused by MRSA.
Requires vancomycin for MRSA coverage, rifampin for biofilm penetration, and gentamicin for synergy.
Monotherapy is insufficient to eradicate biofilm-associated staphylococcal infections on foreign bodies.
3
Select the appropriate targeted therapy for disseminated MAC in advanced HIV.
A multi-drug regimen comprising a macrolide (clarithromycin) and ethambutol.
Dual therapy is required to adequately treat mycobacterial infections and prevent the rapid emergence of resistance.
4
Interpret the resistance pattern of the E. coli in the patient with pyelonephritis and septic shock.
The resistance profile is pathognomonic for an ESBL-producing organism, necessitating treatment with a carbapenem like meropenem.
ESBL-producing enterobacteriaceae readily hydrolyze penicillins, most cephalosporins, and aztreonam, making carbapenems the safest and most effective option for severe infections.

Key Concept

Selection of targeted antimicrobial therapy must account for pathogen resistance profiles, biofilm presence, and host-specific contraindications.
Estimated Time:2m 0s
Question 1322Question →

Match the following developmental milestones, clinical red flags, and pubertal changes to their corresponding expected age thresholds or clinical classifications.

Click a left item, then click its matching right item

Items

Failure to achieve independent walking (warrants neuromuscular evaluation)
Copies a triangle, skips with alternating feet, and can dress independently
Onset of breast bud development (thelarche) in females
Speaks in 2-word phrases, builds a tower of 6 cubes, and follows 2-step commands

Matches

Show answer & explanation

Answer

Failure to achieve independent walking matches with 18 months; copying a triangle and skipping matches with 5 years; the onset of breast bud development matches with Tanner stage II; speaking 2-word phrases and building a 6-cube tower matches with 2 years.
Each clinical finding corresponds directly to well-established pediatric developmental norms and pubertal staging criteria used in well-child assessments.

Step-by-Step Solution

1
Identify the absolute red flag age for independent walking.
Failure to walk independently by 18 months is a recognized red flag.
Most children walk by 12-15 months; lack of this milestone at 18 months requires a workup.
2
Determine the age corresponding to copying a triangle and skipping.
These are 5-year (60-month) milestones.
Copying shapes follows a pattern: circle (3 years), cross/square (4 years), triangle (5 years).
3
Recall the Tanner staging for thelarche.
Breast bud development is the hallmark of Tanner stage II.
Tanner I is prepubertal; Tanner II marks the initial physical changes of puberty.
4
Correlate 2-word phrases and 2-step commands to a developmental age.
These language and cognitive skills are expected at 2 years of age.
The 'rule of 2s' applies here: 2-word phrases, 2-step commands, 2/4 (50%) of speech intelligible to strangers.

Key Concept

Developmental milestones and pubertal staging
Question 1323Question →

A 45-year-old woman is evaluated in the rheumatology clinic and newly diagnosed with highly active, seropositive rheumatoid arthritis (RA). Baseline radiographs reveal early marginal erosions in the metacarpophalangeal joints. Arrange the following clinical steps in the most appropriate chronological order for her long-term management, assuming she exhibits an inadequate response to each successive pharmacological intervention.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Initiate methotrexate → Document failure at 3 months → Perform IGRA screening → Add a TNF inhibitor → Switch to a non-TNF biologic.
The treat-to-target approach for rheumatoid arthritis dictates a strict step-up algorithmic sequence. Initial management relies on conventional synthetic DMARDs, predominantly methotrexate, combined with short-term bridging glucocorticoids. Efficacy must be reassessed after 3 months. If target disease activity is not met, the regimen is escalated, typically by adding a first-line biologic DMARD such as a TNF inhibitor. Crucially, immediately prior to initiating any biologic DMARD, screening for latent tuberculosis with an IGRA is universally mandated to prevent life-threatening reactivation. Finally, if a patient fails to respond adequately to the primary TNF inhibitor, evidence-based guidelines recommend switching to a biologic DMARD utilizing a different mechanism of action, such as an IL-6 inhibitor or anti-CD20 monoclonal antibody.

Step-by-Step Solution

1
Initiate methotrexate with folic acid and bridging glucocorticoids.
First-line conventional synthetic DMARD (csDMARD) therapy is established.
Methotrexate is the standard of care initial therapy for all patients with newly diagnosed, active rheumatoid arthritis.
2
Evaluate disease activity after 3 months.
Failure to achieve low disease activity target is formally documented.
The 'treat-to-target' strategy requires reassessment at 3-6 months to objectively determine if medication escalation is necessary.
3
Perform an interferon-gamma release assay (IGRA).
Patient is screened and cleared for latent tuberculosis.
Latent TB screening is universally mandated before the initiation of any biologic DMARD due to the severe risk of disease reactivation.
4
Add a TNF inhibitor to the current regimen.
Patient is escalated to combination therapy (csDMARD + first-line biologic DMARD).
Addition of a TNF inhibitor is the standard initial biologic escalation step for patients failing methotrexate monotherapy.
5
Switch to an IL-6 receptor antagonist or other non-TNF biologic.
Patient is transitioned to a second-line biologic with a different mechanism.
Secondary loss of efficacy to a TNF inhibitor warrants switching to an agent with a non-TNF mechanism of action.

Key Concept

Sequential Treat-to-Target Management of Rheumatoid Arthritis
Question 1324Question →

A healthy two-year-old boy presents to the outpatient clinic with his father for a routine health maintenance evaluation. The father reports that the child is active, eats a balanced diet, and sleeps well through the night. On observation, the toddler easily kicks a ball, climbs onto the examination table, and stacks a set of six wooden blocks. When evaluating this patient's speech and language progression, which of the following findings is the most age-appropriate expectation?

Show answer & explanation

Answer: Combining two words into simple phrases

Answer

The most appropriate language expectation for a 2-year-old is the ability to combine two words into simple phrases.
At exactly 2 years (24 months) of age, normal language development dictates that a child should be able to combine two words to make simple phrases. At this stage, they can follow two-step commands, their speech is about 50% intelligible to someone they do not know, and their spoken vocabulary ranges from 50 to 200 words.

Step-by-Step Solution

1
Identify the child's age and current milestone presentation.
The patient is 24 months (2 years) old, with normal gross motor (kicking a ball) and fine motor (stacking 6 blocks) skills.
Establishing the correct age anchors the baseline for expected developmental progression across all domains.
2
Recall language milestones specifically for a 24-month-old.
At 2 years, vocabulary reaches ~50-200 words, speech is 50% intelligible to strangers, and the child can speak in 2-word phrases and follow 2-step commands.
Matching the age to the specific developmental domain requested (language) eliminates milestones intended for younger or older children.

Key Concept

Normal language development at 24 months includes a vocabulary of 50-200 words, speech that is 50% intelligible to strangers, and the use of 2-word phrases.
Question 1325Question →

A pediatric resident is preparing for a developmental assessment clinic. The attending physician asks the resident to review the expected chronological progression of fine motor and adaptive skills in healthy children. Arrange the following developmental milestones in the correct chronological order from earliest to latest typical age of acquisition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence from earliest to latest is: Raking grasp (6 months), immature pincer grasp (9 months), spontaneous scribbling (15 months), building a 4-cube tower (18 months), and turning book pages one at a time (24 months).
Fine motor development follows a predictable progression from gross to highly isolated movements. At 6 months, infants use a raking grasp. By 9 months, this refines into an immature pincer grasp (using the pads of the thumb and index finger). At 15 months, toddlers can spontaneously scribble. By 18 months, release control improves, allowing them to build a tower of four cubes. At 24 months, digit isolation is advanced enough to turn book pages one at a time.

Step-by-Step Solution

1
Identify the earliest milestone in the list.
Uses a raking grasp to pick up a small object.
The raking grasp is a primitive fine motor skill that typically develops around 6 months of age.
2
Identify the next milestone in the first year of life.
Uses the pads of the thumb and index finger to pick up an object.
This is the immature pincer grasp, which typically develops at 9 months of age, before the mature pincer grasp appears at 12 months.
3
Identify the 15-month milestone.
Spontaneously scribbles with a crayon.
Spontaneous scribbling begins around 15 months as the toddler gains better control over grasped tools.
4
Identify the 18-month milestone.
Builds a tower of exactly four cubes.
Building a four-cube tower requires enhanced release control and is characteristic of an 18-month-old (progressing from a two-cube tower at 15 months).
5
Identify the latest milestone in the sequence.
Turns book pages one at a time.
Turning book pages one at a time requires highly refined digit isolation and typically emerges at 24 months (2 years) of age.

Key Concept

Chronological progression of fine motor and adaptive developmental milestones in infants and toddlers.
Question 1326Question →

Emergency medical responders bring a 42-year-old female teacher to the emergency department after she was found profoundly disoriented in her classroom. Her husband reports she has experienced worsening fatigue, diffuse headaches, and nausea over the past three days. She has no significant past medical history and takes no medications. On arrival, her temperature is 38.2°C (100.8°F), blood pressure is 145/90 mmHg, pulse is 112/min, and respirations are 18/min. Physical examination is notable for lethargy, mild scleral icterus, and widespread nonblanching purple pinpoint spots over her lower extremities.

Laboratory studies reveal the following:

ParameterResultReference Range
Hemoglobin7.8 g/dL12.0-16.0 g/dL
Platelets18,000/mm³150,000-400,000/mm³
Leukocytes9,500/mm³4,500-11,000/mm³
Blood urea nitrogen34 mg/dL7-18 mg/dL
Creatinine1.9 mg/dL0.6-1.2 mg/dL
Total bilirubin3.8 mg/dL0.1-1.2 mg/dL
Indirect bilirubin2.9 mg/dL0.1-0.8 mg/dL
Lactate dehydrogenase1,250 U/L100-250 U/L
Prothrombin time12 sec11-15 sec
Activated PTT28 sec25-40 sec
Fibrinogen350 mg/dL150-400 mg/dL

A peripheral blood smear demonstrates numerous fragmented red blood cells. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Initiation of plasma exchange

Answer

The most appropriate next step in management is the initiation of plasma exchange.
The correct action is the initiation of plasma exchange. This patient presents with the classic pentad of Thrombotic Thrombocytopenic Purpura (TTP): fever, altered mental status, thrombocytopenia, acute kidney injury (elevated BUN/Creatinine), and microangiopathic hemolytic anemia (anemia, elevated indirect bilirubin, highly elevated LDH, and schistocytes). TTP is caused by severely decreased activity of the von Willebrand factor (vWF)-cleaving protease ADAMTS13, usually due to an acquired autoantibody. This leads to the formation of ultra-large vWF multimers that shear red blood cells and consume platelets in microthrombi throughout the body. Because it is rapidly fatal without treatment, plasma exchange must be initiated immediately upon clinical suspicion. Plasma exchange removes the autoantibodies and the ultra-large vWF multimers, while concurrently replacing the deficient ADAMTS13 enzyme.

Step-by-Step Solution

1
Analyze the clinical presentation and laboratory results to form a diagnosis.
The patient exhibits the classic pentad of Thrombotic Thrombocytopenic Purpura (TTP): microangiopathic hemolytic anemia (MAHA), severe thrombocytopenia, fever, acute kidney injury, and altered mental status.
Recognizing the constellation of symptoms is essential for identifying microangiopathic disorders.
2
Differentiate the suspected diagnosis from other similar coagulopathies.
The normal prothrombin time (PT), normal activated partial thromboplastin time (aPTT), and normal fibrinogen levels rule out Disseminated Intravascular Coagulation (DIC).
DIC involves the massive consumption of coagulation factors, prolonging PT/aPTT, whereas TTP is primarily an issue of platelet aggregation leaving the coagulation cascade intact.
3
Determine the optimal immediate therapeutic intervention.
Plasma exchange (plasmapheresis) must be initiated immediately without waiting for confirmatory ADAMTS13 laboratory results.
TTP is a medical emergency with a high mortality rate if untreated. Plasma exchange rapidly removes the offending autoantibodies and ultra-large von Willebrand factor multimers while replacing the deficient ADAMTS13 enzyme.

Key Concept

Diagnosis and emergent management of Thrombotic Thrombocytopenic Purpura (TTP)
Question 1327Question →

A 42-year-old man with a history of intravenous drug use is brought to the emergency department due to severe lower back pain and an inability to move his legs since this morning. For the past week, he has had worsening back pain and subjective fevers. Today, he also noticed he has been unable to urinate. His temperature is 39.1∘C39.1^\circ\text{C} (102.4∘F102.4^\circ\text{F}), blood pressure is 110/70 mm Hg110/70\text{ mm Hg}, and pulse is 112/min112/\text{min}. Physical examination reveals exquisite point tenderness over the L3-L4 spinous processes. Neurologic examination shows 1/51/5 strength in bilateral lower extremities, decreased sensation below the umbilicus, and absent patellar and Achilles reflexes. Bedside ultrasound reveals 800 mL800\text{ mL} of retained urine.

Arrange the following steps in the most appropriate chronological order for the optimal management of this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: Draw blood cultures -> Initiate empiric antibiotics -> Obtain emergent MRI of the spine -> Perform surgical decompression -> De-escalate to targeted antimicrobial therapy.
This patient has a classic presentation of a spinal epidural abscess (SEA) complicated by acute cauda equina syndrome (paraparesis, saddle anesthesia, urinary retention). The management of SEA with neurologic deficits is a surgical emergency and demands a very specific sequence of interventions. The critical first step is drawing blood cultures, which should ideally never be delayed. Immediately following blood cultures, broad-spectrum empiric antibiotics (covering MRSA and Gram-negatives) must be administered. While obtaining tissue for culture prior to antibiotics is the ideal pathway for stable patients without neurologic compromise, acute cord compression mandates immediate therapy to prevent permanent paralysis. Once antibiotics are infusing, an emergent MRI of the entire spine is required to localize the lesion accurately. This is followed by emergent surgical decompression (e.g., laminectomy) and drainage. Finally, once intraoperative cultures result, the broad-spectrum regimen should be de-escalated to targeted therapy to adhere to antimicrobial stewardship principles.

Step-by-Step Solution

1
Draw two sets of peripheral blood cultures
Maximizes the potential for pathogen identification
Systemic antibiotics rapidly sterilize blood cultures; therefore, cultures must be drawn first, provided it does not cause a significant delay in care.
2
Initiate empiric intravenous vancomycin and cefepime
Broad-spectrum coverage against likely pathogens (e.g., MRSA, Gram-negatives) begins
Acute neurologic deficits necessitate immediate antibiotic administration to salvage neurologic function, superseding the usual preference to hold antibiotics for a tissue biopsy in stable patients.
3
Obtain an emergent magnetic resonance imaging (MRI) of the spine
The epidural abscess is anatomically localized
Surgical planning requires precise delineation of the epidural collection's level and spatial extent.
4
Perform surgical decompression and epidural drainage
Spinal cord pressure is relieved and definitive source control is achieved
Medical therapy alone is insufficient for a large epidural abscess causing acute mechanical cord compression; emergent surgery is required.
5
De-escalate to targeted antimicrobial therapy
Narrow-spectrum, pathogen-specific therapy is established
Once operative cultures return, continuing broad-spectrum antibiotics promotes resistance and toxicity; stewardship principles dictate narrowing coverage.

Key Concept

In patients with suspected spinal epidural abscess presenting with acute neurologic deficits, empiric antibiotics must be administered immediately after blood cultures and before imaging or biopsy to prevent irreversible neurologic injury.
Estimated Time:2m 0s
Question 1328Question →

A 68-year-old man with a history of type 2 diabetes mellitus is brought to the emergency department by his family due to a severe headache, fever, and progressive confusion over the past 24 hours. On physical examination, his temperature is 39.2°C (102.6°F), blood pressure is 112/72 mmHg, heart rate is 115/min, and respiratory rate is 18/min. He is lethargic, opens his eyes to pain, and is oriented only to his name. Marked nuchal rigidity is present. There are no focal motor deficits, but fundoscopic examination is limited due to patient noncompliance. Place the following management steps in the most appropriate sequential order.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Obtain peripheral blood cultures, 2) Administer empiric antibiotics and dexamethasone, 3) Perform a CT scan of the head, 4) Perform a lumbar puncture, 5) De-escalate to targeted therapy.
The standard of care for suspected acute bacterial meningitis requires obtaining blood cultures first, followed immediately by empiric intravenous antibiotics and dexamethasone. Because this patient is >60 years old and has an altered level of consciousness, there is a substantial risk of brain herniation if a lumbar puncture is performed in the presence of elevated intracranial pressure. Therefore, a non-contrast CT of the head is indicated before the lumbar puncture. Crucially, antibiotics must not be delayed while awaiting the CT scan or the lumbar puncture. Once the CT clears the patient for safe procedural access, the lumbar puncture is performed. Finally, once cultures and sensitivities return (typically 48-72 hours later), the broad-spectrum regimen is narrowed to targeted therapy.

Step-by-Step Solution

1
Identify the clinical syndrome and immediate life threats.
The patient presents with the classic triad of meningitis (fever, nuchal rigidity, altered mental status).
Rapid recognition dictates the urgency of intervention.
2
Determine the required diagnostic and therapeutic interventions.
The patient requires blood cultures, broad-spectrum antibiotics with steroids, a CT scan, and a lumbar puncture.
These are the standard components of acute bacterial meningitis management.
3
Sequence the interventions based on established clinical guidelines for high-risk patients.
Because the patient has altered mental status and is older than 60, a CT scan is required before the lumbar puncture to prevent brain herniation. However, antibiotics must not be delayed for the CT scan.
Delaying antibiotics increases mortality. Blood cultures take only minutes and should precede antibiotics. Therefore, the sequence must be: Blood cultures -> Antibiotics -> CT -> LP -> Targeted therapy.

Key Concept

In patients with suspected bacterial meningitis who meet criteria for neuroimaging before a lumbar puncture (e.g., altered mental status, age >60, focal neurologic deficit, immunocompromised), blood cultures and empiric antibiotics must be administered prior to the CT scan to prevent fatal delays in therapy.
Estimated Time:1m 30s
Question 1329Question →

During a routine primary care appointment, a 7171-year-old woman reports experiencing a severe, right-sided headache for the past two weeks. She describes her scalp as being highly sensitive, noting that it hurts simply to brush her hair. Over the last 4848 hours, she has also developed a deep, cramping pain in her jaw that exclusively occurs when she is eating meals. Earlier this morning, she experienced a frightening episode where the vision in her right eye completely went dark for five minutes before spontaneously returning to normal. Her temperature is 37.7∘C37.7^\circ\text{C} (99.9∘F99.9^\circ\text{F}). Physical examination demonstrates a prominent, thickened right temporal artery that is tender to palpation and lacks a palpable pulse. Point-of-care laboratory testing reveals an erythrocyte sedimentation rate of 105 mm/h105\text{ mm/h}.

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Immediate administration of high-dose corticosteroids

Answer

The most appropriate next step is the immediate administration of high-dose corticosteroids to prevent irreversible vision loss caused by giant cell arteritis.
Giant cell arteritis is a large-vessel vasculitis that most commonly affects branches of the carotid artery in older adults. When inflammation involves the ophthalmic artery, it can cause transient vision loss (amaurosis fugax) which rapidly progresses to permanent blindness if left untreated. The immediate priority is administering high-dose systemic corticosteroids (e.g., intravenous methylprednisolone or high-dose oral prednisone depending on severity) to abruptly halt the inflammatory cascade. While a temporal artery biopsy remains the gold standard for a definitive diagnosis, empirical therapy must be initiated the moment clinical suspicion is established, long before the biopsy is scheduled.

Step-by-Step Solution

1
Analyze the patient's demographic and clinical presentation.
The patient is an elderly woman presenting with a new-onset headache, scalp tenderness, jaw claudication, and a transient episode of monocular vision loss (amaurosis fugax).
Identifying the classic triad of symptoms (headache, jaw claudication, vision changes) in a patient over 50 is essential for recognizing the underlying syndrome.
2
Correlate physical examination and laboratory findings with the clinical syndrome.
The thickened, tender temporal artery without a pulse and a markedly elevated erythrocyte sedimentation rate (105 mm/h105\text{ mm/h}) strongly confirm a state of systemic inflammation localized to the cranial arteries.
These findings solidify the clinical diagnosis of giant cell arteritis (temporal arteritis).
3
Determine the urgency and select the most appropriate initial intervention.
Because the patient has already experienced transient vision loss, she is at imminent risk for irreversible blindness (anterior ischemic optic neuropathy). Therefore, high-dose corticosteroids must be administered immediately.
In giant cell arteritis with ischemic complications, reducing vascular inflammation immediately takes precedence over any diagnostic testing to preserve organ function.

Key Concept

Patients with suspected giant cell arteritis (temporal arteritis), especially those with visual symptoms or jaw claudication, require immediate administration of high-dose systemic corticosteroids to prevent irreversible blindness. Treatment should never be delayed for a temporal artery biopsy.
Question 1330Question →

A 62-year-old man presents to the emergency department with a 5-day history of progressively worsening shortness of breath, orthopnea, and lower extremity swelling. He has a 30-pack-year smoking history but quit 5 years ago. He also has a 10-year history of erosive rheumatoid arthritis. His joint symptoms were poorly controlled with methotrexate alone, so etanercept was added 4 months ago, resulting in significant improvement in his joint pain. His other medical conditions include mild depression, for which he takes fluoxetine. Temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 154/92 mm Hg154/92 \text{ mm Hg}, pulse is 108 min−1108 \text{ min}^{-1}, and respirations are 24 min−124 \text{ min}^{-1}. Pulse oximetry on room air shows an oxygen saturation of 91%91\%. Physical examination reveals jugular venous distention. Lung auscultation demonstrates bilateral bibasilar crackles and scattered expiratory wheezes. Cardiac examination reveals tachycardia with a prominent S3 gallop. There is 2+2+ bilateral pitting edema of the lower extremities. Joint examination shows no active synovitis. Laboratory studies show:

Brain natriuretic peptide: 850 pg/mL850 \text{ pg/mL}

Arterial blood gas on room air:
pH:7.49\text{pH}: 7.49
PaCO2:28 mm Hg\text{PaCO}_2: 28 \text{ mm Hg}
PaO2:64 mm Hg\text{PaO}_2: 64 \text{ mm Hg}
HCO3−:21 mEq/L\text{HCO}_3^-: 21 \text{ mEq/L}

Chest radiography reveals cardiomegaly, bilateral alveolar infiltrates, and small bilateral pleural effusions.

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Discontinue etanercept and administer intravenous furosemide

Answer

The most appropriate next step is to discontinue etanercept and administer intravenous furosemide.
This patient with rheumatoid arthritis presents with acute decompensated heart failure, characterized by orthopnea, elevated brain natriuretic peptide, an S3 gallop, jugular venous distention, and pulmonary edema on chest radiography. His heart failure was likely induced by etanercept, a tumor necrosis factor (TNF)-alpha inhibitor. TNF-alpha inhibitors are highly effective disease-modifying antirheumatic drugs (DMARDs) but carry a significant risk of causing new-onset heart failure or exacerbating pre-existing cardiac dysfunction. They are absolutely contraindicated in patients with moderate to severe heart failure. The most appropriate next step in management is to immediately discontinue the offending agent and treat the volume overload with intravenous loop diuretics such as furosemide.

Step-by-Step Solution

1
Analyze the clinical presentation and physical examination findings.
The patient has orthopnea, jugular venous distention, an S3 gallop, and bilateral crackles with wheezing (cardiac asthma).
To differentiate between cardiac, pulmonary, and systemic causes of acute dyspnea.
2
Interpret the diagnostic studies.
Elevated BNP, primary respiratory alkalosis on ABG, and cardiomegaly with pulmonary edema on chest x-ray confirm acute decompensated heart failure.
To confirm the clinical diagnosis and rule out primary pulmonary pathology like a COPD exacerbation or infectious pneumonia.
3
Review the patient's pharmacotherapy history for potential triggers.
The patient was started on etanercept, a tumor necrosis factor (TNF)-alpha inhibitor, 4 months ago.
TNF-alpha inhibitors are a well-documented cause of new-onset heart failure or exacerbation of underlying cardiac dysfunction.
4
Determine the appropriate management.
Discontinue the offending agent (etanercept) and administer loop diuretics (furosemide).
Removal of the trigger and acute diuresis are the mainstays of therapy for biologic-induced acute decompensated heart failure.

Key Concept

Tumor necrosis factor (TNF)-alpha inhibitors (e.g., etanercept, infliximab, adalimumab) can cause new-onset heart failure or exacerbate underlying cardiac dysfunction; they must be discontinued immediately if heart failure develops.
Question 1331Question →

An emergency medical services team brings a 7272-year-old man to the acute care clinic due to a three-day history of escalating dyspnea and lower extremity swelling. He reports coughing up clear sputum and finds it difficult to lie flat at night. His past medical history includes chronic obstructive pulmonary disease (COPD), diet-controlled hypertension, and osteoarthritis. Current medications include inhaled tiotropium and as-needed albuterol.

His temperature is 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure is 156/92 mm Hg156/92\text{ mm Hg}, pulse is 108/min108/\text{min}, and respirations are 26/min26/\text{min}. Pulse oximetry shows 87%87\% on room air. Physical examination reveals jugular venous distention up to 9 cm H2O9\text{ cm H}_2\text{O}. Lung auscultation demonstrates bibasilar crackles extending to the mid-lung fields and prolonged expiration with scattered wheezes. Cardiac examination shows a regular, rapid rhythm with an audible S 3_3 gallop. There is 2+2+ pitting edema in both lower extremities.

Laboratory results are as follows:

TestResultReference Range
Leukocyte count8,400/mm38,400/\text{mm}^34,000−11,000/mm34,000-11,000/\text{mm}^3
B-type natriuretic peptide (BNP)1,250 pg/mL1,250\text{ pg/mL}<100 pg/mL<100\text{ pg/mL}
Thyroid-stimulating hormone (TSH)0.2 μU/mL0.2\ \mu\text{U/mL}0.4−4.0 μU/mL0.4-4.0\ \mu\text{U/mL}
Free thyroxine (T4)1.3 ng/dL1.3\text{ ng/dL}0.9−1.7 ng/dL0.9-1.7\text{ ng/dL}
Arterial pH7.307.307.35−7.457.35-7.45
Arterial pCO2_260 mm Hg60\text{ mm Hg}35−45 mm Hg35-45\text{ mm Hg}
Arterial pO2_254 mm Hg54\text{ mm Hg}75−105 mm Hg75-105\text{ mm Hg}
Arterial HCO3−_3^-28 mEq/L28\text{ mEq/L}22−28 mEq/L22-28\text{ mEq/L}

Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Intravenous furosemide and supplemental oxygen

Answer

Intravenous furosemide and supplemental oxygen
The patient is experiencing acute decompensated heart failure (ADHF). Despite a history of COPD and the presence of wheezing, the key differentiating factors are the elevated jugular venous pressure, an S3 gallop, profound pitting edema, and a highly elevated BNP level. The wheezing in this context is known as 'cardiac asthma', caused by peribronchial edema. The mainstay of initial therapy for ADHF with volume overload is preload reduction, typically achieved with intravenous loop diuretics (e.g., furosemide) alongside supplemental oxygen or noninvasive positive pressure ventilation to correct hypoxemia.

Step-by-Step Solution

1
Interpret the physical exam and diagnostic findings to establish the primary diagnosis.
The presence of jugular venous distention, an S3 gallop, bibasilar crackles, pitting edema, and a BNP of 1,250 pg/mL indicates acute decompensated heart failure (ADHF).
It is critical to differentiate ADHF from a COPD exacerbation. While the patient has COPD and wheezes, the cardiac findings and BNP firmly point to cardiac asthma and pulmonary edema.
2
Analyze the arterial blood gas and secondary laboratory findings.
The ABG reveals an acute-on-chronic respiratory acidosis (low pH, high pCO2, and mildly elevated bicarbonate). The thyroid panel shows euthyroid sick syndrome (low TSH, normal free T4).
Understanding the acid-base status ensures that treatments exacerbating acidosis (like bicarbonate) are avoided. Recognizing euthyroid sick syndrome prevents unnecessary antithyroid medications.
3
Select the most appropriate acute intervention for the primary diagnosis.
Intravenous furosemide and supplemental oxygen are selected.
Loop diuretics provide rapid preload reduction and diuresis, which relieves the pulmonary congestion driving the patient's respiratory failure.

Key Concept

Diagnosis and acute management of acute decompensated heart failure (ADHF) presenting with cardiac asthma in a patient with comorbid COPD.
Question 1332Question →

A 12-month-old girl is brought to the clinic for a routine well-child visit. She was diagnosed with acute lymphoblastic leukemia three months ago and is currently receiving induction chemotherapy. The parents are concerned about her development because she cannot run yet. Her mother reports that the child stands independently, takes a few steps on her own, uses a neat pincer grasp, specifically calls her parents "mama" and "dada", and waves goodbye. The parents ask which vaccines she is allowed to receive today. Which of the following is the most appropriate recommendation for this patient?

Show answer & explanation

Answer: Administer the Haemophilus influenzae type b vaccine

Answer

The most appropriate recommendation is to administer the Haemophilus influenzae type b vaccine, as it is an inactivated vaccine and safe for immunocompromised hosts.
The patient is severely immunocompromised due to active chemotherapy for acute lymphoblastic leukemia. In this setting, live-attenuated vaccines are absolutely contraindicated due to the risk of causing severe, disseminated disease. However, inactivated and conjugate vaccines, such as the Haemophilus influenzae type b (Hib) vaccine, are completely safe to administer. The patient's development is entirely normal for her age (she has achieved her 12-month milestones of standing, initial independent steps, neat pincer grasp, and specific babbling), so there is no indication for a developmental evaluation.

Step-by-Step Solution

1
Assess the patient's immune status based on her medical history.
The patient is actively receiving induction chemotherapy for acute lymphoblastic leukemia, which means she is severely immunocompromised.
A patient's immune status determines whether they can safely receive live-attenuated vaccines.
2
Evaluate the patient's developmental milestones for her age (12 months).
Her abilities to stand independently, take a few steps, use a neat pincer grasp, wave, and specifically say "mama/dada" are all age-appropriate milestones. The inability to run is also normal, as running is typically achieved around 18 months.
To address the parents' concerns and determine if a developmental referral is indicated.
3
Determine the appropriate 12-month vaccines that are safe to administer.
Live-attenuated vaccines (MMR, varicella) must be withheld due to the risk of severe infection. Inactivated or conjugate vaccines (such as the Haemophilus influenzae type b vaccine) are safe to administer.
Immunocompromised patients cannot control the replication of the weakened viruses in live vaccines.

Key Concept

Live-attenuated vaccines are strongly contraindicated in severely immunocompromised patients (e.g., those on active chemotherapy). Inactivated, toxoid, and conjugate vaccines are safe to administer.
Question 1333Question →

A 38-year-old man comes to the emergency department due to persistent high fever, drenching sweats, and dark-colored urine. Five days ago, he was evaluated at an urgent care clinic for an expanding, target-shaped erythematous rash on his right calf and a mild headache. The symptoms began a week after a hiking trip in Rhode Island. He was diagnosed with early localized Lyme disease and prescribed oral doxycycline.

Despite adherence to the medication, the rash has faded but his fevers have worsened. Over the past 48 hours, he developed profound fatigue and noticed his eyes appearing yellow. Vital signs show a temperature of 39.4°C (102.9°F), blood pressure of 112/70 mmHg, and heart rate of 115/min. Physical examination is notable for mild scleral icterus. The abdomen is soft, with a spleen tip palpable below the left costal margin.

Laboratory evaluation shows:
- Hemoglobin: 8.6 g/dL
- Platelet count: 88,000/mm³
- Total bilirubin: 3.5 mg/dL
- Direct bilirubin: 0.5 mg/dL
- Lactate dehydrogenase: 720 U/L

A peripheral blood smear reveals intraerythrocytic pleomorphic ring forms. Which of the following is the most appropriate modification to this patient's antimicrobial regimen?

Show answer & explanation

Answer: Continue doxycycline and add atovaquone and azithromycin

Answer

Continue doxycycline and add atovaquone and azithromycin
The correct answer involves continuing the current Lyme disease treatment and adding targeted therapy for babesiosis. This patient's presentation of fever, hemolytic anemia (elevated indirect bilirubin and LDH), thrombocytopenia, and intraerythrocytic ring forms is diagnostic of babesiosis. *Babesia microti* is a parasite transmitted by the *Ixodes scapularis* tick, which is also the vector for *Borrelia burgdorferi* (Lyme disease) and *Anaplasma phagocytophilum* (anaplasmosis). Coinfection is common in endemic areas like the Northeastern United States. While the patient's early localized Lyme disease is being appropriately treated with doxycycline, this antibiotic has no efficacy against *Babesia*. Therefore, a specific anti-parasitic regimen of atovaquone and azithromycin must be added to treat the babesiosis.

Step-by-Step Solution

1
Identify the primary presentation
The patient has clinical signs of hemolytic anemia (jaundice, high indirect bilirubin, high LDH, low hemoglobin) and a peripheral smear showing intraerythrocytic ring forms.
To establish the specific cause of the new and worsening systemic symptoms.
2
Relate findings to the epidemiological context
The patient has a recent history of early localized Lyme disease following a tick bite in Rhode Island, an endemic area for the Ixodes scapularis tick.
To evaluate for potential tick-borne coinfections.
3
Determine the appropriate targeted therapy
The findings are diagnostic of Babesia microti coinfection. Doxycycline covers Lyme disease but not Babesia; therefore, targeted anti-parasitic therapy with atovaquone and azithromycin must be added.
To select the correct, narrow-spectrum treatment indicated by the diagnostic data, avoiding inappropriate broad-spectrum antibiotics.

Key Concept

Patients with tick-borne illnesses from endemic regions can present with coinfections (e.g., Lyme disease and babesiosis). Babesiosis requires targeted therapy with atovaquone and azithromycin, as the standard treatments for Lyme disease (such as doxycycline) are ineffective against Babesia.
Estimated Time:1m 30s
Question 1334Question →

During morning rounds, a 64-year-old woman is evaluated on her third hospital day for management of acute pyelonephritis. She initially presented to the emergency department with a temperature of 38.9°C (102.0°F), right-sided flank pain, and persistent emesis. Blood and urine cultures were drawn, and empiric intravenous piperacillin-tazobactam was initiated.

Today, the patient reports feeling much better. Her flank pain has nearly resolved, and she is eating a regular diet without nausea. She has been afebrile for the past 24 hours. Current vital signs are temperature 37.1°C (98.8°F), heart rate 78/min, and blood pressure 118/76 mm Hg.

The admission blood and urine cultures are now finalizing, both demonstrating heavy growth of *Escherichia coli*. The isolate susceptibility report is as follows:

Antimicrobial AgentSusceptibility
AmpicillinResistant
CeftriaxoneSusceptible
CiprofloxacinSusceptible
FosfomycinSusceptible
Piperacillin-tazobactamSusceptible
Trimethoprim-sulfamethoxazoleSusceptible

The patient has no known drug allergies. Her serum creatinine is 0.80.8 mg/dL.

Which of the following is the most appropriate next step in pharmacologic management?

Show answer & explanation

Answer: Transition to oral trimethoprim-sulfamethoxazole

Answer

Transition to oral trimethoprim-sulfamethoxazole
The correct decision is to transition the patient to oral trimethoprim-sulfamethoxazole. This patient was admitted with bacteremic acute pyelonephritis and has rapidly improved on empiric intravenous therapy. Because she has been afebrile for at least 24 hours, is hemodynamically stable, and is tolerating an oral diet, she is an excellent candidate for step-down to oral antibiotics. The goal of antimicrobial stewardship is to utilize the narrowest effective agent with appropriate pharmacokinetics for the site of infection. Trimethoprim-sulfamethoxazole has excellent oral bioavailability and achieves high concentrations in both the serum and renal parenchyma. This choice safely facilitates hospital discharge while avoiding unnecessarily broad antibiotics.

Step-by-Step Solution

1
Assess the patient's clinical trajectory to determine eligibility for intravenous to oral transition.
The patient is afebrile for 24 hours, hemodynamically stable, and tolerating a regular diet.
Meeting these criteria indicates the patient can safely absorb and respond to oral antimicrobial therapy.
2
Evaluate the susceptibility report to identify viable oral step-down options.
The isolate is susceptible to ciprofloxacin, fosfomycin, and trimethoprim-sulfamethoxazole.
Oral step-down requires an agent that is active against the specific pathogen isolated.
3
Select the most appropriate oral agent based on pharmacokinetics and antimicrobial stewardship.
Trimethoprim-sulfamethoxazole is selected.
Fosfomycin lacks adequate renal tissue penetration for pyelonephritis. Ciprofloxacin is excessively broad and carries severe side effect warnings. Trimethoprim-sulfamethoxazole provides excellent tissue penetration with a narrower spectrum.

Key Concept

Antimicrobial stewardship in transitioning from intravenous to oral therapy for complicated urinary tract infections.
Estimated Time:1m 15s
Question 1335Question →

A 31-year-old man presents to the emergency department with a 5-week history of productive cough, low-grade fever, drenching night sweats, and a 55-kg (1111-lb) weight loss. He emigrated from an area with high tuberculosis prevalence three years ago and currently resides in a crowded apartment. His temperature is 38.4∘38.4^\circ C (101.1∘101.1^\circ F), blood pressure is 118/76118/76 mm Hg, pulse is 9292/min, and respirations are 2020/min. Oxygen saturation is 96%96\% on room air. Pulmonary examination reveals bronchial breath sounds and crackles in the right upper lung field. A chest radiograph demonstrates a cavitary infiltrate in the right upper lobe.

Arrange the following interventions in the most appropriate chronological order for the management of this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct management sequence is: 1) Place the patient in a negative-pressure airborne infection isolation room, 2) Collect sputum specimens for AFB smear and culture, 3) Initiate intensive phase therapy with a 4-drug regimen, and 4) De-escalate to a 2-drug continuation phase therapy.
The correct chronological order for managing a patient with highly suspected active pulmonary tuberculosis begins with immediate airborne isolation, followed by diagnostic sampling, initiation of empiric multi-drug therapy, and finally, targeted de-escalation. Immediate placement in a negative-pressure airborne infection isolation room is the critical first step to prevent nosocomial transmission. Once the patient is isolated, diagnostic sputum specimens must be collected before administering any antimicrobials, as therapy can rapidly render cultures negative and preclude necessary drug susceptibility testing. Following specimen collection, standard intensive phase therapy with a 4-drug regimen (isoniazid, rifampin, pyrazinamide, and ethambutol) is initiated to quickly decrease the mycobacterial burden. After completing 2 months of this intensive phase and confirming organism susceptibility, the regimen is de-escalated to a 2-drug continuation phase (isoniazid and rifampin) for an additional 4 months to achieve a definitive cure.

Step-by-Step Solution

1
Address immediate public health and infection control priorities.
Place the patient in a negative-pressure airborne infection isolation room.
Tuberculosis is spread via airborne droplet nuclei. Prompt isolation is mandatory to prevent nosocomial transmission to staff and other vulnerable patients.
2
Determine the necessary diagnostic sequence before initiating pharmacotherapy.
Collect sputum specimens for acid-fast bacilli (AFB) smear, culture, and nucleic acid amplification testing.
Diagnostic specimens must be obtained prior to antimicrobial administration because empiric therapy can rapidly sterilize the sputum, preventing crucial organism isolation and drug susceptibility testing.
3
Select the appropriate initial empiric pharmacologic intervention.
Initiate intensive phase therapy with isoniazid, rifampin, pyrazinamide, and ethambutol.
A 4-drug regimen is required for the initial 2-month intensive phase to rapidly reduce the mycobacterial burden and prevent the emergence of drug resistance.
4
Identify the correct step-down management strategy following the initial treatment phase.
De-escalate to continuation phase therapy with isoniazid and rifampin.
After completing 2 months of intensive therapy and confirming susceptibility, treatment is simplified to a 2-drug continuation phase for an additional 4 months to eradicate remaining persister organisms.

Key Concept

Management sequence of active pulmonary tuberculosis: Airborne isolation, followed by diagnostic specimen collection, initiation of 4-drug intensive therapy, and subsequent de-escalation to 2-drug continuation therapy.
Question 1336Question →

A 32-year-old man is brought to the emergency department due to a 3-day history of progressively worsening, severe right upper quadrant abdominal pain and abdominal swelling. Over the past year, he has experienced significant fatigue and several episodes where his urine appeared abnormally dark, particularly upon waking in the morning. His temperature is 37.8∘C37.8^\circ\text{C} (100.0∘F100.0^\circ\text{F}), blood pressure is 112/68 mm Hg112/68 \text{ mm Hg}, and pulse is 108/min108/\text{min}. Physical examination reveals scleral icterus, mildly labored breathing, and a markedly distended abdomen with shifting dullness. There is severe tenderness to palpation in the right upper quadrant. The liver edge is palpable 4 cm4 \text{ cm} below the right costal margin.

Laboratory results are as follows:

TestResultReference Range
Hemoglobin8.5 g/dL8.5 \text{ g/dL}13.5−17.5 g/dL13.5-17.5 \text{ g/dL}
Mean corpuscular volume92 fL92 \text{ fL}80−100 fL80-100 \text{ fL}
Platelet count105,000/mm3105,000/\text{mm}^3150,000−400,000/mm3150,000-400,000/\text{mm}^3
Leukocyte count3,800/mm33,800/\text{mm}^34,500−11,000/mm34,500-11,000/\text{mm}^3
Reticulocyte count8%8\%0.5−1.5%0.5-1.5\%
Total bilirubin5.1 mg/dL5.1 \text{ mg/dL}0.1−1.2 mg/dL0.1-1.2 \text{ mg/dL}
Direct bilirubin0.6 mg/dL0.6 \text{ mg/dL}0.0−0.3 mg/dL0.0-0.3 \text{ mg/dL}
Lactate dehydrogenase1,450 U/L1,450 \text{ U/L}100−250 U/L100-250 \text{ U/L}
Haptoglobin<10 mg/dL<10 \text{ mg/dL}41−165 mg/dL41-165 \text{ mg/dL}

Abdominal duplex ultrasonography shows a prominently enlarged liver with moderate ascites and absent color flow signal within the hepatic veins.

Which of the following therapies directly targets the primary etiology of this patient's current condition?

Show answer & explanation

Answer: Administration of a monoclonal antibody against complement protein C5

Answer

Administration of a monoclonal antibody against complement protein C5
The correct answer is the administration of a monoclonal antibody against complement protein C5 (Eculizumab). This patient's presentation of intravascular hemolysis (anemia, elevated LDH, low haptoglobin, unconjugated hyperbilirubinemia, reticulocytosis), pancytopenia (low platelets, low WBCs), morning hemoglobinuria, and hepatic vein thrombosis (Budd-Chiari syndrome) is highly characteristic of Paroxysmal Nocturnal Hemoglobinuria (PNH). PNH is an acquired clonal hematopoietic stem cell disorder caused by a mutation in the PIGA gene, which leads to a deficiency of glycosylphosphatidylinositol (GPI) anchor proteins (most notably CD55 and CD59). The absence of these regulatory proteins on the cell surface makes red blood cells highly susceptible to complement-mediated destruction. Thrombosis, particularly in atypical sites such as the hepatic, cerebral, or mesenteric veins, is the leading cause of morbidity and mortality in PNH. Eculizumab binds to the terminal complement protein C5, preventing the formation of the membrane attack complex. This effectively halts intravascular hemolysis and significantly reduces the risk of further thrombotic events.

Step-by-Step Solution

1
Analyze the clinical presentation and laboratory findings to identify the primary mechanism of disease.
The patient has severe right upper quadrant pain, hepatomegaly, and ascites. Labs reveal pancytopenia, marked intravascular hemolysis (high LDH, low haptoglobin, unconjugated hyperbilirubinemia, reticulocytosis), and a history of morning dark urine (hemoglobinuria).
Identifying the constellation of findings is essential to narrow the differential diagnosis for acute hepatomegaly with severe anemia.
2
Interpret the diagnostic imaging in the context of the clinical picture.
Abdominal duplex ultrasound shows absent color flow in the hepatic veins, confirming the diagnosis of Budd-Chiari syndrome (hepatic vein thrombosis).
Budd-Chiari syndrome is a life-threatening complication that frequently occurs in the setting of underlying hypercoagulable states, guiding the search for a hematologic disorder.
3
Synthesize the findings of intravascular hemolysis, pancytopenia, and atypical venous thrombosis.
The combination of Coombs-negative intravascular hemolysis, pancytopenia, and intra-abdominal venous thrombosis strongly points to Paroxysmal Nocturnal Hemoglobinuria (PNH).
PNH is a clonal stem cell disorder characterized by a lack of GPI-anchored complement inhibitors (CD55, CD59), leading to unregulated complement-mediated RBC lysis and a highly thrombogenic state.
4
Determine the targeted pharmacotherapy for the identified condition.
Eculizumab, a monoclonal antibody targeting complement protein C5, is the definitive therapy to halt complement-mediated hemolysis and reduce thrombotic risk in PNH.
Blocking the terminal complement cascade prevents the formation of the membrane attack complex, which is the root pathogenesis in PNH.

Key Concept

Paroxysmal Nocturnal Hemoglobinuria (PNH) classic triad (hemolytic anemia, pancytopenia, and venous thrombosis) and its targeted management with C5 complement inhibitors.
Question 1337Question →

An ambulance brings a 71-year-old male to the emergency department due to severe shortness of breath that awoke him from sleep. He has a known medical background of chronic obstructive pulmonary disease and ischemic heart failure with a reduced ejection fraction. Over the past three days, he has noted increasing difficulty breathing when lying flat and has had to sleep in a recliner chair. He denies fever, chills, or changes in sputum production. His temperature is 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure is 170/95 mm Hg170/95\text{ mm Hg}, pulse is 115/min115/\text{min}, and respirations are 28/min28/\text{min}. Oxygen saturation is 86%86\% on room air. Examination reveals distended jugular veins when sitting at a 45-degree angle. Pulmonary auscultation demonstrates bilateral crackles up to the mid-lung fields without significant wheezing. Cardiac auscultation reveals a regular tachycardia with an S3 gallop. A bedside chest radiograph demonstrates an enlarged cardiac silhouette, prominent pulmonary vasculature, and bilateral pleural effusions. Which of the following is the most appropriate initial pharmacological intervention for this patient?

Show answer & explanation

Answer: Intravenous furosemide

Answer

Intravenous furosemide
The correct answer is intravenous furosemide because this patient is presenting with classic signs of acute decompensated heart failure (ADHF). Despite his history of chronic obstructive pulmonary disease (COPD), his symptoms of orthopnea, paroxysmal nocturnal dyspnea, jugular venous distention, an S3 gallop, and crackles on exam strongly indicate volume overload. The chest radiograph showing cardiomegaly, prominent vasculature, and pleural effusions confirms cardiogenic pulmonary edema. The primary treatment for ADHF with volume overload is intravenous loop diuretics (such as furosemide) to reduce preload and relieve pulmonary congestion.

Step-by-Step Solution

1
Analyze the patient's presenting symptoms and history.
The patient has orthopnea, paroxysmal nocturnal dyspnea, and a history of both heart failure and COPD.
Identifying key symptoms helps differentiate between the patient's two underlying chronic diseases.
2
Evaluate the physical examination and imaging findings.
Findings include jugular venous distention, crackles, an S3 gallop, cardiomegaly, and pleural effusions, all without fever or prominent wheezing.
These specific signs strongly indicate volume overload and acute cardiogenic pulmonary edema.
3
Select the appropriate pharmacological intervention.
Intravenous furosemide is chosen to rapidly induce diuresis and relieve pulmonary congestion.
Loop diuretics are the standard of care for acute decompensated heart failure presenting with volume overload.

Key Concept

Patients presenting with acute decompensated heart failure (characterized by orthopnea, paroxysmal nocturnal dyspnea, JVD, an S3 gallop, and pulmonary crackles) require prompt diuresis with intravenous loop diuretics, even if they have a concurrent history of COPD.
Question 1338Question →

A ward nurse urgently requests an evaluation of a 71-year-old male who developed severe, sudden-onset shortness of breath 20 minutes ago. The patient is currently on postoperative day 3 following an elective sigmoid resection for recurrent diverticulitis. His medical history is significant for ischemic heart disease, diet-controlled type 2 diabetes mellitus, and a 40-pack-year smoking history. Over the past 24 hours, he received 3 liters of intravenous lactated Ringer's solution for transient oliguria.

Vital signs are:
- Temperature: 37.2°C (99.0°F)
- Blood pressure: 168/94 mm Hg
- Pulse: 112/min
- Respirations: 26/min
- Oxygen saturation: 87% on room air

Physical examination reveals an agitated, diaphoretic man sitting upright and using accessory muscles of respiration. The jugular veins are distended to the angle of the mandible when the patient is seated at a 45-degree angle. Cardiac auscultation reveals a regular tachycardia with a distinct, low-pitched additional heart sound heard in early diastole. Lung auscultation demonstrates prolonged expiration with diffuse polyphonic wheezing and bilateral moist crackles in the lower lung fields.

Arterial blood gas analysis on room air shows:
- pH: 7.287.28
- pCO 2_2: 5454 mm Hg
- pO 2_2: 5656 mm Hg
- HCO 3−_3^-: 2424 mEq/L

Which of the following is the most appropriate initial management for this patient?

Show answer & explanation

Answer: Intravenous furosemide administration

Answer

Intravenous furosemide administration
The correct answer is the administration of a loop diuretic. This patient's acute respiratory distress, hypoxemia, marked jugular venous distention, S3 gallop, and bibasilar crackles following aggressive intravenous fluid resuscitation strongly indicate acute decompensated heart failure (ADHF) complicated by cardiogenic pulmonary edema. The wheezing noted on examination is a manifestation of 'cardiac asthma', which occurs when peribronchial edema compresses the small airways and causes bronchospasm. The initial management for ADHF with volume overload requires immediate preload reduction, which is most effectively achieved with intravenous loop diuretics (e.g., furosemide) alongside supplemental oxygen or noninvasive positive-pressure ventilation.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and vital signs.
The patient has acute respiratory failure (hypoxia, tachypnea, respiratory acidosis) in the setting of recent aggressive intravenous fluid resuscitation.
Establishing the severity and context of the respiratory failure is essential for prioritizing interventions.
2
Interpret the physical examination findings.
Jugular venous distention, a prominent S3 gallop, and bilateral crackles indicate severe volume overload and left ventricular dysfunction.
These classic signs differentiate cardiogenic causes of dyspnea from primary pulmonary causes.
3
Correlate the lung examination with the cardiac findings.
The presence of wheezing alongside heart failure signs represents 'cardiac asthma', caused by peribronchial edema, rather than a primary COPD exacerbation.
Misinterpreting the wheezing could lead to the wrong treatment pathway.
4
Select the most appropriate initial pharmacologic therapy.
Intravenous furosemide is selected to provide rapid preload reduction and relieve pulmonary congestion.
Loop diuretics form the cornerstone of acute management for volume-overloaded acute decompensated heart failure.

Key Concept

Acute decompensated heart failure can present with wheezing (cardiac asthma); diagnosis relies on recognizing concurrent signs of volume overload (S3 gallop, jugular venous distention), and initial management requires preload reduction with loop diuretics.
Estimated Time:1m 30s
Question 1339Question →

A physician is evaluating a 64-year-old male patient who reports the sudden onset of profuse, watery diarrhea and lower abdominal cramps that began three days ago. The patient recently completed a 10-day course of clindamycin for a dental abscess. He currently experiences up to nine bowel movements daily. His temperature is 37.9∘C37.9^\circ\text{C} (100.2∘F100.2^\circ\text{F}), pulse is 92/min92/\text{min}, and blood pressure is 118/76 mm Hg118/76\text{ mm Hg}. Physical examination of the abdomen reveals mild, diffuse tenderness without rebound or guarding. Laboratory results show a leukocyte count of 15,500/mm315,500/\text{mm}^3. Stool testing is positive for *Clostridioides difficile* toxin via nucleic acid amplification testing. Which of the following is the most appropriate pharmacologic intervention for this patient's current condition?

Show answer & explanation

Answer: Administration of oral vancomycin

Answer

Administration of oral vancomycin
The patient has an initial episode of Clostridioides difficile infection (CDI), likely precipitated by recent clindamycin use. According to current clinical guidelines, the first-line treatment for an initial episode of CDI is oral vancomycin or oral fidaxomicin. Oral vancomycin is poorly absorbed, allowing it to achieve very high, effective intraluminal concentrations directly at the site of the infection in the colon.

Step-by-Step Solution

1
Analyze the patient's clinical presentation and laboratory results.
The patient has a history of recent clindamycin use and presents with acute watery diarrhea. Stool testing confirms the presence of Clostridioides difficile toxin.
Identifying the correct diagnosis is the prerequisite for selecting the appropriate targeted therapy.
2
Determine the severity and specific treatment indication for the identified infection.
This is an initial episode of Clostridioides difficile infection. The standard of care requires targeted oral antibiotic therapy.
Treatment guidelines dictate specific medications based on whether it is an initial or recurrent episode, and disease severity.
3
Select the most appropriate pharmacologic agent from the available options.
Oral vancomycin is chosen over the alternatives because it achieves high luminal concentrations and is recommended as first-line therapy.
Intravenous vancomycin does not reach the colonic lumen, and oral metronidazole is no longer considered first-line for initial episodes.

Key Concept

The first-line treatment for an initial episode of Clostridioides difficile infection is oral vancomycin or oral fidaxomicin.
Estimated Time:1m 0s
Question 1340Question →

A 55-year-old man presents to a rural emergency department reporting severe, crushing, substernal chest pain of 45 minutes duration that radiates to his left jaw. He appears diaphoretic and dyspneic. His blood pressure is 145/90 mm Hg and heart rate is 92/min. A 12-lead electrocardiogram demonstrates 4 mm ST-segment elevations in leads V2 through V5. The facility does not have a cardiac catheterization laboratory. The nearest percutaneous coronary intervention (PCI)-capable center is located 140 minutes away by helicopter transport, and weather conditions are clear for flying. Arrange the following management steps in the most appropriate chronological sequence for this patient.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with immediate administration of aspirin, followed by intravenous tenecteplase, transfer to a PCI-capable facility, subsequent coronary angiography, and finally optimization of secondary prevention medications.
The correct sequence reflects the standard of care for an acute ST-elevation myocardial infarction presenting to a non-PCI capable center with an anticipated transport time exceeding 120 minutes. Immediate stabilization with aspirin is followed by fibrinolytic therapy within 30 minutes. A pharmacoinvasive strategy then dictates immediate transfer to a capable center for early routine angiography and stenting. Finally, secondary prevention is initiated prior to hospital discharge.

Step-by-Step Solution

1
Administer immediate medical stabilization therapy.
Chewable aspirin is given upon identifying ischemic chest pain.
Aspirin permanently inhibits platelet cyclooxygenase, reducing thrombus expansion, and is the absolute first step in acute coronary syndrome management.
2
Assess the reperfusion timeline to select between primary PCI and fibrinolysis.
Intravenous tenecteplase is administered.
The guideline-directed threshold for primary PCI is a first medical contact-to-device time of less than 120 minutes. Since the transfer alone is 140 minutes, fibrinolytics must be given within 30 minutes of arrival.
3
Initiate a pharmacoinvasive strategy after fibrinolysis.
The patient is transferred to the PCI-capable hospital.
Fibrinolysis does not definitively treat the underlying ruptured plaque; all patients require transfer for early routine angiography or rescue PCI if reperfusion fails.
4
Assess and treat the culprit coronary lesion.
Coronary angiography is performed.
Visualizing the coronary tree allows for definitive stenting (PCI) of the residual stenosis, typically performed 2 to 24 hours after successful fibrinolysis.
5
Implement long-term cardiovascular risk reduction.
Secondary prevention pharmacotherapy is optimized.
Before discharge, initiating medications such as beta-blockers, ACE inhibitors, and high-intensity statins is required to prevent ventricular remodeling and recurrent ischemic events.

Key Concept

STEMI Reperfusion Strategy and Timeline
Estimated Time:1m 30s
PreviousPage 67 / 414Next
All practice questions — USMLE Step 2 CK | Examkin